According to a recent announcement, the European Commission (EU) has granted market authorization for a new subcutaneous formulation of ocrelizumab (Ocrevus; Roche), administered twice-yearly as a 10-minute injection for patients with multiple sclerosis (MS). The subcutaneous injection was designed to be administered by healthcare professionals, with the flexibility to administer either in the clinic or in settings outside the clinic.
EU Approves Subcutaneous Formulation of ... - My MSAA Community
EU Approves Subcutaneous Formulation of Ocrelizumab for Multiple Sclerosis Treatment
![BettysMom profile image](https://images.hu-production.be/avatars/474ecfd5d3648316531853c1086487ff_small@2x_100x100.jpg)
Written by
![BettysMom profile image](https://images.hu-production.be/avatars/474ecfd5d3648316531853c1086487ff_small@2x_100x100.jpg)
BettysMom
To view profiles and participate in discussions please or .
Read more about...
4 Replies
•
I saw that same information and I am quite intrigued by it. Thanks for sharing it.
When I posted this I did not know that the subject had already been discussed on this site. However, this is very important news so I think that repeating it may serve a purpose.
Not what you're looking for?
You may also like...
As the Clash says, should I stay or should I go?
Today was that ever elusive good day, when I’m sure I can drive and be ok long enough for there and...
Stormy 2nd Surgery
My poor pup has to have surgery again tomorrow morning to remove his dew claw. It just hasn’t...
Daughter has Cancer
I told you that my dog had surgery Friday morning, but my day went downhill from there fast. Emily,...
Can Anyone Who has Discontinued Ocrevus Please Tell Me What Happens With Crap Gap Symptoms?
Hi all, I posted a while back about stopping Ocrevus and starting Mavenclad. I am turning into a...
Crazy week for me and the hubby...
This week started off fairly well, only for it to start going downhill from Wednesday. I woke up...